Henrietta Fore, Stacy Enxing Seng Join Imperative Care Board

Imperative Care Inc. has appointed Henrietta Fore and Stacy Enxing Seng to its Board of Directors.
 
“The addition of Henrietta and Stacy to Imperative Care’s Board of Directors will prove invaluable as they bring varied backgrounds and areas of expertise both within and outside of the medical device industry,” said Fred Khosravi, CEO and chairman of Imperative Care. “We have worked very deliberately in our efforts to attract extraordinary people to Imperative Care’s Board, as the right balance of knowledge, experience, and thoughtful governance is absolutely critical to achieving our mission of transforming medical innovation and bringing better care to more patients.”
 
As an accomplished executive leader, Enxing Seng has more than 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, demonstrated clinical outcomes, management teams, and company cultures. She brings a strong track record of helping develop and advance life-saving technologies from early concept to valuable solutions in the hands of physicians. She has been recognized as one of Minnesota’s Top 100 Women in Business and currently holds numerous independent director positions at Fogarty Innovation, Sonova Holding AG, LivaNova plc, and Corza Medical, and serves as board chair for Contego Medical and Cala Health. Additionally, she has been an operating partner at Lightstone Ventures since 2016.

Enxing Seng earned a bachelor of arts degree in public policy from Michigan State University and an MBA from Harvard Business School.
 
“This is an exciting time for Imperative Care. The company is undergoing rapid and meaningful growth with its successful stroke treatment portfolio, while nurturing development programs that look beyond stroke intervention and tackle gaps across the entire stroke patient journey. Together with Truvic, Imperative Care is poised to be a strong leader in the vascular space, and I look forward to working alongside the company’s board members and executive leadership team to further advance this urgent and patient-focused mission,” said Enxing Seng.
 
Fore joins the company’s board with more than four decades of public service in a variety of sectors. She recently served as the seventh executive director of United Nations Children’s Fund and currently is board chairman and CEO of Holsman International, a manufacturing and consulting company. Under President George W. Bush, Fore served as the first female Administrator of the United States Agency for International Development (USAID) and Director of U.S. Foreign Assistance, Under Secretary of Management in the Department of State, and Director of the United States Mint. She has held a number of other leadership positions such as an independent director for ExxonMobil and General Mills. Fore has also received esteemed honors such as the United States Secretary of State’s Distinguished Service Award in 2009.

Fore earned a bachelor of arts degree in history, economics, and art from Wellesley College and a master’s of science degree in public administration from the University of Northern Colorado.
 
“Stroke is a devastating disease impacting more than 15 million people worldwide each year, according to the World Health Organization. Navigating stroke care from detection through recovery is critical to improving patient outcomes. Imperative Care is working to provide a complete solution that increases access to patient care, improves stroke treatment, and helps patients return to their daily activities,” said Fore. “The company is leveraging innovative solutions in stroke care for patients suffering from devastating vascular diseases, and I look forward to helping guide Imperative Care as it progresses in this purposeful mission.”
 
“We are pleased to have both Stacy and Henrietta join our esteemed board of leaders,” said John Hamre, Ph.D., chairman of Imperative Care’s Nominating and Governance Committee. “These women are inspirational forces in their respective fields. They bring a wealth of knowledge and experience that will undoubtedly help us meet the highest possible standards on behalf of patients and the clinical community.”
 
Imperative Care  develops next-generation solutions to address stroke needs. The company has two 510(k) cleared product platforms, as well as a stroke technology development pipeline. In addition, Imperative Care’s wholly owned subsidiary, Truvic, is developing solutions for treating peripheral vascular disease. Imperative Care and Truvic are based in Campbell, Calif.